Table 1.
Association of VM expression with clinicopathological characteristics in 76 PDAC patients
| Characteristics | No. of patients | VM expression | P-value | ||
|---|---|---|---|---|---|
|
| |||||
| n | % | Negative | Positive | ||
| Age (years) | 0.362 | ||||
| ≤ 60 | 23 | 30.3 | 7 | 16 | |
| > 60 | 53 | 69.7 | 11 | 42 | |
| Gender | 0.733 | ||||
| Male | 49 | 64.5 | 11 | 38 | |
| Female | 27 | 35.5 | 7 | 20 | |
| Clinical stage | 0.049* | ||||
| Early stages (≤ Ia) | 12 | 15.8 | 6 | 6 | |
| Advanced stages (> Ia) | 64 | 84.2 | 12 | 52 | |
| Invasion depth | 0.759 | ||||
| T1 + T2 | 17 | 22.4 | 5 | 12 | |
| T3 + T4 | 59 | 77.6 | 13 | 46 | |
| Lymph nodes metastasis | 0.023* | ||||
| N0 (negative) | 33 | 43.4 | 12 | 21 | |
| N1 (positive) | 43 | 56.6 | 6 | 37 | |
| Distant metastasis | 0.567 | ||||
| M0 (Absent) | 72 | 94..7 | 18 | 54 | |
| M1 (Present) | 4 | 5.3 | 0 | 4 | |
| Tumor differentiation | 0.233 | ||||
| Well, moderate | 51 | 67.1 | 10 | 41 | |
| Poor | 25 | 32.9 | 8 | 17 | |
| Tumor location | 0.081 | ||||
| Head, neck | 39 | 51.3 | 6 | 33 | |
| Body, tail | 37 | 48.7 | 12 | 25 | |
| Nervous invasion | 0.077 | ||||
| Negative | 25 | 32.9 | 9 | 16 | |
| Positive | 51 | 67.1 | 9 | 42 | |
| Vessal invasion | 0.397 | ||||
| Negative | 65 | 85.5 | 17 | 48 | |
| Positive | 11 | 14.5 | 1 | 10 | |
*
P<0.05 indicates a significant association among the variables.